Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript : vimarsana.com

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript February 22, 2024 Rhythm Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.7 EPS, expectations were $-0.7. Rhythm Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies […]

Related Keywords

Germany , Italy , Japan , France , United States , Netherlands , Spain , Nagoya , Aichi , United Kingdom , Canada , French , Japanese , Yann Mazabraud , Hunter Smith , David Meeker , Japanese Pediatric Neurosurgery Society , International Region , Japanese Society For Hypothalamic , Early Access Program , Japanese Brain Tumor Registry , Nagoya City , Japanese Society , Pituitary Tumors , Dow Jones Dividend Stocks According , Wind Power , David Connolly , Hythm , Avid Meeker , Apan , Bs , Apanese Patients , Edicaid , Ave Connolly ,